At a glance
| Our verdict | A body-clock signal, not a sleeping pill: for a late body clock, jet lag, and prolonged-release 2 mg at 55+. Not for ordinary insomnia under 55. |
| Best use | Body clock: jet lag, shift work, a late body clock |
| How sure the evidence is | Moderate for a late body clock |
| Cost a month | About $1.50 to $3 |
Written for adults in Canada. It explains the evidence; it is not advice for you personally. Last reviewed 20 October 2026.
Supplement Check
Is it right for you?
Melatonin helps only some sleep problems, and the timing matters more than the dose. Your check asks when you fall asleep, whether you travel or work nights, screens for sleep apnoea and checks your medicines first. Our Supplement Check looks at:
- Pregnancy, planning a pregnancy, or breastfeeding: every Canadian melatonin licence read says not to use it
- Possible sleep apnoea: loud snoring, pauses in breathing seen by a partner, daytime sleepiness, higher weight or high blood pressure
- Epilepsy or a past seizure
- An autoimmune condition, or a medicine that dampens the immune system
- Taking fluvoxamine or warfarin
- Every medicine you take
Coming soon. The Supplement Check and the Online Health Assessment open once our safety testing is complete.
$59 when it opens, paid once. Adults 18 and over, anywhere in Canada. While the service is new, Dr. French reads every report himself, and your report arrives within 3 working days. More about the Supplement Check
What it is
Melatonin is the hormone the pineal gland releases in darkness, starting about 2 hours before your usual sleep time. In Canada it is sold as a licensed natural health product from 0.1 to 10 mg; of 834 active licences, only 53 are 1 mg and 4 are 0.5 mg, while most are 3, 5 or 10 mg. [1]
Prolonged-release 2 mg (Circadin) is the product tested in older adults. Canadian timed-release 2 mg products exist but have not themselves been tested in trials.
Which product. A single-ingredient 1 mg tablet (half a tablet gives 0.5 mg). We have not yet named a brand: no Canadian maker publishes batch melatonin results, and we are asking for a certificate of analysis first. Gummies and combinations (with 5-HTP, L-theanine or herbs) are not used.
How it acts
Melatonin acts on receptors in the brain's master clock. It has two separate effects.
- It moves the clock. Taken in the afternoon or early evening it moves the clock earlier; taken early in the morning it moves it later; taken at bedtime it barely moves it at all. At its best time, 3 mg moved the clock up to about 1.8 hours earlier over 3 days, [2] and 0.5 mg, taken at its own best time, moved it by a similar amount. [3] In people with a late clock, the earlier the dose was taken relative to their own melatonin rise, the larger the shift. [4]
- A mild sleep-promoting effect, mainly when your own melatonin is low. It is not a sedative like a sleeping pill. [5]
That is why the timing matters more than the dose.
What it is used for, and what the evidence says
| Use | What the trials found | How sure we are |
|---|---|---|
| Late body clock (delayed sleep–wake phase) | 116 adults, 4 weeks: 0.5 mg 1 hour before the desired bedtime, plus a fixed sleep schedule, against placebo with the same schedule. Falling asleep 34 minutes earlier (somewhere between 8 and 60 minutes); 52.8% against 24.0% rated improved by a clinician; side effects similar to placebo. [6] The American Academy of Sleep Medicine endorses timed melatonin for this. [7] | Moderate |
| Jet lag, 5 or more time zones | A Cochrane review of 10 small trials: 9 found that melatonin at destination bedtime reduced jet lag. For every 2 people who take it, one benefits. 0.5 to 5 mg worked similarly; more than 5 mg was no better; the benefit was greater flying east. Taken early in the day it causes sleepiness and delays adapting. [8] | Low to Moderate |
| Shift work: sleeping in the day after a night shift | 9 trials, 1 to 10 mg after the shift: 24 minutes more daytime sleep, but no faster falling asleep, and no difference by dose. [9] | Low |
| Insomnia at 55 and over, prolonged-release 2 mg | 354 people aged 55 to 80, 3 weeks: better sleep quality and morning alertness in 26% against 15%; falling asleep 24 minutes faster against 13 on placebo. [10] Over 6 months: 19 minutes faster against 2, no loss of effect, side effects similar to placebo. [11] Both trials were funded by the maker. | Low to Moderate |
| Ordinary insomnia | 19 trials, 1,683 people: falling asleep 7 minutes faster and 8 minutes more sleep. [5] The American Academy of Sleep Medicine suggests not using it for chronic insomnia. [12] | Moderate (that the effect is small) |
| Dementia with disturbed sleep | The American Academy of Sleep Medicine recommends against it. [7] | Low (not recommended) |
How sure we are: High means further research is very unlikely to change the answer; Moderate, it might; Low, it may well change; Very low, we are very unsure. These follow the GRADE method that guideline panels use.
Benefits
- Late body clock: falling asleep about 34 minutes earlier, with a fixed schedule (moderate certainty).
- Jet lag: 1 in 2 people helped (low to moderate certainty).
- After a night shift: about 24 minutes more daytime sleep (low certainty).
- Insomnia at 55 and over, prolonged-release 2 mg: falling asleep about 19 minutes faster than placebo (low to moderate).
- Ordinary insomnia: about 7 minutes, which is too small to recommend.
- Cheap: $1.50 to $3 a month.
Risks and side effects
- Next-day drowsiness, headache, dizziness, vivid dreams, nausea. In the late-clock trial, light-headedness, daytime sleepiness and lower sex drive occurred at rates similar to placebo. [6]
- Wrong time, wrong direction. Taken in the morning it moves the clock the wrong way and makes you sleepy. [8]
- Blood sugar. In a 2026 crossover trial of 21 people, 5 mg worsened glucose handling by 11.7% and cut the first burst of insulin by 40% in carriers of a common diabetes-risk gene variant (about 30% of people of European ancestry). [13] Another reason to keep the dose at 0.5 to 1 mg and not take it with a late meal.
- Labels you cannot trust. Canadian products tested contained from 83% less to 478% more melatonin than the label, varied up to 465% between batches of the same product, and 8 of 31 contained serotonin. [14]
- Children. In the US, poison-centre reports of children swallowing melatonin rose 530% in 10 years; 5 needed a breathing machine and 2 died. [15] Keep it out of reach.
Interactions with medicines
Melatonin does not change how the liver clears other medicines. The reverse is the problem: it is cleared mainly by one liver enzyme (CYP1A2), and medicines that block that enzyme raise melatonin levels.
| Medicine | What can happen | What to do |
|---|---|---|
| Fluvoxamine | Melatonin exposure 17 times higher [16] | Do not take; see a doctor |
| Warfarin | Case reports of a change in INR [8] | Held for a doctor |
| Transplant and other immune-suppressing medicines | Licence: consult first [1] | Held for a doctor |
| Sleeping pills, benzodiazepines, opioids, gabapentin, pregabalin, sedating antihistamines; alcohol | Added drowsiness [1] | Caution; start at 0.5 mg; no alcohol |
| Ciprofloxacin, enoxacin | Higher melatonin levels (enzyme blocked) | Caution while on the course |
| Oral oestrogen (the pill, hormone therapy) | Higher melatonin levels | Start at 0.5 mg |
| Seizure medicines, blood-pressure medicines, steroids | Licence: consult first [1] | Caution |
| Smoking | Speeds clearance; lower levels | No action |
Who should not take it
- Pregnancy, planning a pregnancy, or breastfeeding: every Canadian melatonin licence read says not to use it. [1]
- Possible sleep apnoea: loud snoring, pauses in breathing seen by a partner, daytime sleepiness, higher weight or high blood pressure. Dr. French's rule: sleep apnoea is checked before any sleep product.
- Epilepsy or a past seizure: a doctor first (no conclusion is possible from the trials). [17]
- An autoimmune condition, or a medicine that dampens the immune system: a doctor first.
- Taking fluvoxamine or warfarin.
- Diabetes: caution; low dose, not with a late meal. Heart, liver or kidney disease, or asthma: the licence says consult. [1]
- No driving or machinery for 5 hours after a dose (night-shift workers: take it only once home).
- Insomnia lasting more than 4 weeks: see a doctor.
- Dementia with disturbed sleep: not recommended.
- Children: only with their doctor. Under 18: outside the Supplement Check.
Dose and timing
- Late body clock: 0.5 to 1 mg, 3 to 5 hours before the time you now fall asleep (or, as in the trial, 1 hour before your desired bedtime with a fixed wake time). Move it 30 to 60 minutes earlier every few days as your sleep moves. 4 to 6 weeks, then review. [3, 6]
- Jet lag, flying east across 5 or more time zones: 0.5 to 3 mg at local bedtime (10 pm to midnight) for the first 2 to 5 nights after arrival. Never in the morning. Flying west it is usually not needed.
- Night shifts: 1 mg (up to 3 mg) just before your daytime sleep, only once you are home.
- Insomnia at 55 and over: prolonged-release 2 mg, 1 to 2 hours before bed, for up to 3 months, if a sleep programme (cognitive behavioural therapy for insomnia) has not helped enough.
- With every clock problem: the same wake time every day, outdoor daylight within an hour of waking, and dim light for the last 2 hours before bed. Melatonin helps these work; it does not replace them.
- One product only. If you already take melatonin, replace it, never add.
- How to tell it is working: a sleep diary or wearable for 2 weeks before and 4 weeks on. For a late clock, the aim is falling asleep within 30 minutes of your desired bedtime on most nights. No change after 4 weeks at the right time: stop and book.
- Store at room temperature, dry and dark.
What we know about Canadians
About 1 in 6 Canadian adults (16.3%) had insomnia disorder in a 2023 national survey. In one year, 28.7% used natural or over-the-counter sleep aids, 15.6% cannabis, 14.7% prescribed sleeping pills and 9.7% alcohol. [18] Night-time insomnia symptoms affect 18 to 20% of adults and 24% of women aged 18 to 64. [19]
Sleep apnoea is the problem often missed: among Canadians aged 45 to 85, 28.1% were at high risk of moderate-to-severe sleep apnoea (27.5% in New Brunswick), and about 93% of them had not been diagnosed. [20] That is why we screen before any sleep product.
Most at risk of insomnia: women, Indigenous people, people in poorer mental or physical health; older adults (more prescribed pills) and young adults (more cannabis, alcohol and over-the-counter products).
How sure are we: moderate. National surveys with standard criteria, but self-reported; sleep apnoea risk is from a screening questionnaire, not sleep studies.
An honest comparison: sleep and the body clock
Effects against placebo where trials report them, with the cost a month in Canadian dollars. No medicine is approved to move the body clock; sleeping pills treat sleeplessness, not timing.
| Option | Effect | How sure we are | Cost a month (CAD) |
|---|---|---|---|
| Melatonin 0.5 mg, late body clock | 34 minutes earlier to sleep, on top of the schedule [6] | Moderate | $1.50 to $3 |
| Melatonin, prolonged-release 2 mg, age 55 and over | About 19 minutes faster to sleep against 2 on placebo [11] | Low to Moderate | $3 to $5 |
| Melatonin, ordinary insomnia | 7 minutes faster to sleep [5] | Moderate (small) | $1.50 to $3 |
| Cognitive behavioural therapy for insomnia (app, programme or therapist) | 19 minutes faster to sleep, 26 minutes less awake in the night; lasts after treatment ends [21] | Moderate to High | Free (app) to about $90 (therapist) |
| Fixed wake time, morning daylight, dim evenings | The schedule both groups followed in the late-clock trial; not measured on its own [6] | Not graded | Free |
| Sleeping pill (zopiclone in Canada) | 22 minutes faster to sleep while taken; [22] over 60, about 5 times the rate of memory and thinking side effects; [23] no help to day sleep after night shifts [9] | Moderate | $8 to $12 |
Read honestly: for a late body clock, low-dose melatonin at the right time is the best option we have, cheap and safe. For ordinary insomnia it does almost nothing; a sleep programme works better and keeps working after you stop.
Our verdict
For adults with a late body clock (unable to fall asleep before 1 or 2 in the morning and struggling to wake): 0.5 to 1 mg, timed, with a fixed wake time and morning light. For jet lag flying east across 5 or more time zones: 0.5 to 3 mg at local bedtime. After night shifts: 1 mg before daytime sleep. At 55 and over with insomnia that a sleep programme has not fixed: prolonged-release 2 mg for up to 3 months.
Not for ordinary insomnia under 55, not in pregnancy or breastfeeding, not with fluvoxamine, and not before sleep apnoea has been considered.
Melatonin is a timing signal, not a sedative. Taken at the right time, a small dose moves the body clock about as much as a large one, with fewer side effects, and for a late clock no medicine does the job. For ordinary sleeplessness it saves about 7 minutes, and a sleep programme works better and lasts. Dr. French approved melatonin for these uses at these doses (0.5 to 1 mg for the body clock, 0.5 to 3 mg for jet lag, 2 mg prolonged-release at 55 and over) and not for ordinary insomnia. Because almost 3 in 10 Canadians over 45 are at high risk of sleep apnoea and most do not know it, his rule is that apnoea is checked before any sleep product. And because Canadian labels are unreliable, we name a brand only once its maker has shown us a batch test.
Supplement Check
Before you buy it, get it checked
Melatonin helps only some sleep problems, and the timing matters more than the dose. Your check asks when you fall asleep, whether you travel or work nights, screens for sleep apnoea and checks your medicines first. Our Supplement Check looks at:
- Pregnancy, planning a pregnancy, or breastfeeding: every Canadian melatonin licence read says not to use it
- Possible sleep apnoea: loud snoring, pauses in breathing seen by a partner, daytime sleepiness, higher weight or high blood pressure
- Epilepsy or a past seizure
- An autoimmune condition, or a medicine that dampens the immune system
- Taking fluvoxamine or warfarin
- Every medicine you take
Coming soon. The Supplement Check and the Online Health Assessment open once our safety testing is complete.
$59 when it opens, paid once. Adults 18 and over, anywhere in Canada. While the service is new, Dr. French reads every report himself, and your report arrives within 3 working days. More about the Supplement Check
Disclosure of financial interest
White Pine Medical earns money from products bought through our Fullscript dispensary. Dr. French's Code of Ethics requires him to tell you this. You do not have to buy anything from us: every product is named by its ingredient and dose so you can buy it at any pharmacy, and the advice is the same wherever you buy it, or if you buy nothing.
References
- Health Canada. Licensed Natural Health Products Database: risk, purpose and dose records for two licensed melatonin products; ingredient records for all 834 active melatonin licences [Internet]. Ottawa: Health Canada; [read 20 Oct 2026]. Available from: https://health-products.canada.ca/api/natural-licences/
- Burgess HJ, Revell VL, Eastman CI. A three pulse phase response curve to three milligrams of melatonin in humans. J Physiol. 2008;586(2):639-47.
- Burgess HJ, Revell VL, Molina TA, Eastman CI. Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mg. J Clin Endocrinol Metab. 2010;95(7):3325-31.
- Mundey K, Benloucif S, Harsanyi K, Dubocovich ML, Zee PC. Phase-dependent treatment of delayed sleep phase syndrome with melatonin. Sleep. 2005;28(10):1271-8.
- Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One. 2013;8(5):e63773.
- Sletten TL, Magee M, Murray JM, Gordon CJ, Lovato N, Kennaway DJ, et al. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: a double-blind, randomised clinical trial. PLoS Med. 2018;15(6):e1002587.
- Auger RR, Burgess HJ, Emens JS, Deriy LV, Thomas SM, Sharkey KM. Clinical practice guideline for the treatment of intrinsic circadian rhythm sleep-wake disorders: advanced sleep-wake phase disorder (ASWPD), delayed sleep-wake phase disorder (DSWPD), non-24-hour sleep-wake rhythm disorder (N24SWD), and irregular sleep-wake rhythm disorder (ISWRD). An update for 2015. J Clin Sleep Med. 2015;11(10):1199-236.
- Herxheimer A, Petrie KJ. Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst Rev. 2002;(2):CD001520.
- Liira J, Verbeek JH, Costa G, Driscoll TR, Sallinen M, Isotalo LK, et al. Pharmacological interventions for sleepiness and sleep disturbances caused by shift work. Cochrane Database Syst Rev. 2014;2014(8):CD009776.
- Wade AG, Ford I, Crawford G, McMahon AD, Nir T, Laudon M, et al. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes. Curr Med Res Opin. 2007;23(10):2597-605.
- Wade AG, Ford I, Crawford G, McConnachie A, Nir T, Laudon M, et al. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety. BMC Med. 2010;8:51.
- Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307-49.
- Qian J, Stefanovski D, Andersen PAK, Vujovic N, Kelly L, Lepson J, et al. Melatonin impairs glucose tolerance, first-phase insulin secretion, and insulin feedback inhibition; interaction with MTNR1B diabetes risk variant. Diabetes Care. 2026;49(8):1498-506.
- Erland LA, Saxena PK. Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content. J Clin Sleep Med. 2017;13(2):275-81.
- Lelak K, Vohra V, Neuman MI, Toce MS, Sethuraman U. Pediatric melatonin ingestions - United States, 2012-2021. MMWR Morb Mortal Wkly Rep. 2022;71(22):725-9.
- Härtter S, Grözinger M, Weigmann H, Röschke J, Hiemke C. Increased bioavailability of oral melatonin after fluvoxamine coadministration. Clin Pharmacol Ther. 2000;67(1):1-6.
- Brigo F, Igwe SC, Del Felice A. Melatonin as add-on treatment for epilepsy. Cochrane Database Syst Rev. 2016;2016(8):CD006967.
- Morin CM, Vézina-Im LA, Chen SJ, Ivers H, Carney CE, Chaput JP, et al. Prevalence of insomnia and use of sleep aids among adults in Canada. Sleep Med. 2024;124:338-45.
- Chaput JP, Morin CM, Robillard R, Carney CE, Dang-Vu TT, Davidson JR, et al. Trends in nighttime insomnia symptoms in Canada from 2007 to 2021. Sleep Med. 2025;125:21-6.
- Rizzo D, Baltzan M, Sirpal S, Dosman J, Kaminska M, Chung F. Prevalence and regional distribution of obstructive sleep apnea in Canada: analysis from the Canadian Longitudinal Study on Aging. Can J Public Health. 2024;115(6):970-9.
- Trauer JM, Qian MY, Doyle JS, Rajaratnam SM, Cunnington D. Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis. Ann Intern Med. 2015;163(3):191-204.
- Huedo-Medina TB, Kirsch I, Middlemass J, Klonizakis M, Siriwardena AN. Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration. BMJ. 2012;345:e8343.
- Glass J, Lanctôt KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005;331(7526):1169.
Costs marked as estimates are typical Canadian retail or pharmacy prices, before any drug plan. Certainty grades are ours unless the review gave its own.